Recordati · 20 hours ago
Associate Commercial Forecasting Director
Recordati is a global pharmaceutical company focused on developing and commercializing medicines for common and rare diseases. The Associate Commercial Forecasting Director will lead U.S. forecasting processes, build and maintain models, and collaborate with various stakeholders to ensure accurate and actionable forecasts for the Endocrinology portfolio.
BiotechnologyHealth CareManufacturing
Responsibilities
Lead U.S. forecasting processes across all horizons (monthly/LBE, annual budget, long range plan) with focus on the Endocrinology franchise
Build and maintain dynamic, assumption-driven models supporting Commercial, Supply Planning, and Long‑Range Plan submissions; ensure version control and change management. Standardize templates/approaches, when possible
Ensure strong forecasting governance, including version control, documentation, and clear change management rationale
Partner with Data & Analytics to improve methodologies at regional and territory levels, where applicable
Align assumptions with Marketing, Market Access, Business Unit leads, Finance, GM, and Global teams
Collaborate closely with Finance on quarterly re forecasting, budget cycles, and long range plan development
Proactively stress-test and update forecast assumptions using the latest market data, Competitive Intelligence (CI), market research, RWE, and payer advisory boards
Clearly articulate monthly results vs. forecast, drivers, and implications, as well as risks and opportunities in forecasts
Depending on experience and bandwidth, there may be opportunities to contribute to GTN forecasting as well, which requires detailed understanding of applicable inputs to GTN calculations (e.g. channel mix, government pricing, etc.)
Support Business Development evaluations and Global forecasting, as needed
Establish solid forecasting governance, templates, dashboards, and digital tools, where applicable
Provide analytics thought leadership and develop creative ad‑hoc models to address commercial questions (e.g., scenario planning, expansions, label changes, LOE dynamics)
Manage vendors effectively; support data audits when needed and develop new forecast models for new portfolio products. Perform other duties as may be assigned. Embrace artificial intelligence platforms where appropriate to help drive efficiency and effectiveness in work
Act in full compliance with all laws, regulations, and policies including adverse events / pharmacovigilance responsibilities
Perform additional duties as may be assigned
Qualification
Required
Bachelor's degree required
Minimum 8+ years' experience in Finance, Commercial, Forecasting, or Business Development within the biopharmaceutical industry
Excellent project and task management skills including proactivity, planning, prioritization, objective setting, meeting management and plan execution
Good communication skills, problem solving, follow-through, and agility required
Able to analyze and understand complex data and succinctly communicate findings and projections to leadership
Able to work independently and take lead role on assigned projects
While being organized, and logical, must balance this with a high degree of flexibility to change direction when needed
A confident self-starter, who can work independently and creatively but also be a team player
Champion ideas and support others to achieve goals
Proficient in Excel (e.g. Pivot tables, v-lookups, etc.)
Comfortable working with BI reporting tools (e.g. PowerBI, Tableau) as well as PowerPoint, Word, Outlook and Teams
Benefits
Health Insurance: Medical, dental, orthodontia, vision, life & ADD, short and long-term disability insurance benefits.
Retirement Benefits: 401k
Paid Time Off: Vacation, holiday, and sick/personal time
Company
Recordati
Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange.
Funding
Current Stage
Public CompanyTotal Funding
unknown2018-12-01Undisclosed
2018-06-29Acquired
1995-03-24IPO
Leadership Team
Giovanni Recordati
Founder
Recent News
Venture Capital
2026-01-09
Company data provided by crunchbase